Is regular screening for prostate cancer really necessary?
A panel of experts from the United Kingdom is asking whether regular screening for prostate cancer actually brings enough benefits to outweigh the risks.
Why does hormone therapy worsen some prostate cancers?
Some prostate cancers resist androgen-targeting therapy and continue to spread because the treatment alters the environment of tumor cells, a study shows.
What are the natural ways to prevent prostate cancer?
Age, genetics, and a poor diet are among the many risk factors for prostate cancer. By taking certain steps, a person may be able to reduce their risk. For example, adding soy products and coffee to the diet may help. Learn about natural ways to prevent prostate cancer here.
New technique treats prostate cancer in just five radiotherapy sessions
A new clinical trial proves the benefits of an innovative form of radiotherapy that reduces the treatment to five sessions instead of the usual 37.
Fighting prostate cancer with groundbreaking new technique
Creating a way to keep prostate cancer cells alive in the laboratory for longer leads to quicker drug trials. Sharing this widely speeds it up further.
What makes prostate cancer become aggressive? Study investigates
Using a range of tools, researchers identify a plausible mechanism and genes through which a genetic variation influences prostate cancer aggressiveness.
Prostate cancer: New drug for aggressive, resistant cases
Enzalutamide reduced metastasis or death risk by 71 percent in phase III trial of castration-resistant nonmetastatic prostate cancer with escalating PSA.
Prostate cancer: Scientists find 63 'new genetic markers'
Research locates new genetic markers that may show an elevated risk of developing prostate cancer. This will help to identify men who need early screening.
Immunotherapy effective against 'untreatable' prostate cancer
For the first time, a major clinical trial shows that immunotherapy can successfully treat very advanced forms of prostate cancer.
Targeting this gene could kill prostate cancer
Could a long noncoding RNA that has a role in androgen receptor signaling in prostate cancer be a treatment target that does not lead to resistance?